Found: 6
Select item for more details and to access through your institution.
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 7, p. 1623, doi. 10.1093/ndt/gfac311
- By:
- Publication type:
- Article
Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients.
- Published in:
- Microorganisms, 2022, v. 10, n. 1, p. 4, doi. 10.3390/microorganisms10010004
- By:
- Publication type:
- Article
DKK3 as a potential novel biomarker in patients with autosomal polycystic kidney disease.
- Published in:
- Clinical Kidney Journal, 2024, v. 17, n. 1, p. 1, doi. 10.1093/ckj/sfad262
- By:
- Publication type:
- Article
Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 11, p. 2194, doi. 10.1093/ckj/sfad118
- By:
- Publication type:
- Article
Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects.
- Published in:
- Clinical Kidney Journal, 2022, v. 15, n. 6, p. 1079, doi. 10.1093/ckj/sfab162
- By:
- Publication type:
- Article
Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 12, p. 2646, doi. 10.3390/v14122646
- By:
- Publication type:
- Article